Effect of supplementation in treatment of women with gestational diabetes

Phase 3

Completed

Conditions: Gestational diabetes.
Diabetes mellitus in pregnancy, unspecified
O24.9

Registration Number: IRCT201706045623N116

Lead Sponsor: Vice chancellor for research, Iran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 60

Inclusion Criteria

Patients with gestational diabetes
Aged 18 to 40 years

Exclusion Criteria

Intake of magnesium, zinc, calcium and/or vitamin D supplements during the last 3 months
Taking insulin
Placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Smokers

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Using HOMA formula.

Secondary Outcome Measures

Name	Time	Method
Triglycerides. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;Total cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;LDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;VLDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;FPG. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.